MedTech Terms
    The authoritative reference
    All terms
    Market SegmentsStrategic Landscape

    Endoscopy Devices

    Flexible and rigid scopes plus accessories used for visualization, diagnosis, and therapy inside the GI tract, airways, urinary tract, and joints.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

    Definition

    The endoscopy segment covers flexible video gastroscopes, colonoscopes, duodenoscopes, bronchoscopes, ureteroscopes, and rigid arthroscopes, together with the light sources, processors, capnography, insufflators, and single-use accessories (snares, biopsy forceps, hemoclips) that complete a procedure. The market splits between reusable scopes (capital + reprocessing) and a fast-growing single-use segment driven by infection-control concerns following duodenoscope-associated CRE outbreaks (FDA 2015-2019 safety communications).
    What the regulation says
    Most flexible endoscopes are Class II 510(k) devices under 21 CFR 876 (gastroenterology-urology) or 874 (ENT). FDA's reprocessing guidance and the duodenoscope safety communications materially changed expectations for reprocessing validation, single-use components (caps, elevators), and post-market surveillance studies (522 orders).

    What this means in practice

    Single-use scopes (Ambu, Boston Scientific Exalt) and disposable elevator caps reset the segment's economics. AI-assisted polyp detection (CADe) is now a major sub-segment with multiple FDA-cleared products (e.g., GI Genius, Endoscreener).
    Common pitfalls
    • •Underestimating reprocessing validation requirements — FDA expects multi-cycle worst-case soiling validation.
    • •Treating an AI overlay as a feature rather than a separate SaMD requiring its own clearance.
    • •Ignoring FDA 522 post-market surveillance orders applicable to duodenoscopes.

    Frequently asked questions

    Repeated CRE and other multidrug-resistant infection outbreaks tied to incomplete reprocessing of the elevator mechanism led FDA to recommend transition to disposable-component or fully single-use designs in 2019.

    Primary references

    3 sources
    Link health: 2 verified 1 bot-blocked· last checked 2026-05-09
    FDA·1eCFR·1MedTech Dive·1
    1. 1
      FDA — Duodenoscope Reprocessing
      Bot-blocked
      FDAfda.gov
    2. 2
      21 CFR 876 Gastroenterology-Urology Devices
      Verified
      eCFRecfr.gov
    3. 3
      MedTech Dive
      Verified
      MedTech Divemedtechdive.com

    Inline markers like [1] jump to the matching reference above.